FROM MOLECULE...TO HUMAN
To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
All the news of the Institute of life sciences Frédéric Joliot
The High Throughput Screening Platform, based at the molecular labeling and bio-organic chemistry Unit (SCBM), combines the equipment necessary for high throughput biological screening and the preparation of targeted libraries.
The PARI platform ("RNA Interference Platform") is a screening technological platform dedicated to high-throughput functional genomics on human cell lines. It is located within the Integrative Biology and Molecular Genetics Unit (SBIGeM).
The Saclay Biophysics platform is an integral part of the Paris-South node of the FRISBI infrastructure. The Bioenergetics, Structural Biology and Mechanisms Unit (SB2SM) hosts numerous facilities for analyzes ranging from electron transfer to three-dimensional structures and protein production.
The spectrophotometer park of the Drug Metabolism Research Laboratory, part of the Pharmacology and Immunoanalysis unit (SPI), is part of the MetabolomeIDF platform, itself an integral part of INBS MetaboHUB.
The ProdIg platform is an integral part of the Immunoanalysis Studies and Research Laboratory, of the Pharmacology and Immunoanalysis Unit (SPI). It offers three types of services: production of rabbit polyclonal antibodies, production of mouse monoclonal antibodies and sale of polyclonal or monoclonal antibodies.
SMArt-MS is a platform dedicated to the absolute quantification of small molecules, drugs, metabolites and biomarkers in biological fluids. It is located within the Pharmacology and Immunoanalysis Unit (SPI).
The Level 3 microbiological high-security laboratory is an installation designed to protect the experimenter and the environment from risks associated with the handling of hazardous biological products. attached to the Immunoanalysis Studies and Research Laboratory of the Pharmacology and Immunoanalysis Unit (SPI).
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.